NASDAQ: CMPS - COMPASS Pathways plc

Lønnsomhet i seks måneder: -50.9%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan COMPASS Pathways plc

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet COMPASS Pathways plc

COMPASS Pathways plc работает как компания по охране психического здоровья в Соединенном Королевстве и Соединенных Штатах. Он разрабатывает COMP360, препарат псилоцибина, который находится в стадии клинических испытаний IIb для лечения пациентов с устойчивой к лечению депрессией. Компания ранее была известна как COMPASS Rx Limited и сменила свое название на COMPASS Pathways plc в августе 2020 года. COMPASS Pathways plc была зарегистрирована в 2020 году и базируется в Чешире, Великобритания.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2020-09-18
ISIN US20451W1018
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.compasspathways.com
Цена ао 3.56
Prisendring per dag: -4.56% (3.73)
Prisendring per uke: -11.44% (4.02)
Prisendring per måned: -13.38% (4.11)
Prisendring over 3 måneder: -19.27% (4.41)
Prisendring over seks måneder: -50.9% (7.25)
Prisendring per år: -63.65% (9.795)
Prisendring over 3 år: -74.84% (14.15)
Prisendring over 5 år: 0% (3.56)
Prisendring over 10 år: 0% (3.56)
Prisendring siden begynnelsen av året: -5.82% (3.78)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 2 7
P/E 0 0
EV/EBITDA -1.92 0
Total: 3.38

Effektivitet

Navn Betydning Karakter
ROA, % -43.09 0
ROE, % -52.68 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.2272 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 486.29 10
Lønnsomhet EPS, % 157.95 10
Total: 8
Flere detaljer

Transaksjonsdato Avsløringsdato Insider Type Pris Volum Mengde Del opp til, % Del etterpå, % Dokument
26.09.2024 27.09.2024 ATAI Life Sciences N.V.
10% Owner		 Salg 6.05 16 093 000 2660000 0 -6.37 link
17.04.2024 18.04.2024 Malievskaia Ekaterina
10% Owner		 Salg 8.78 95 263 10850 0 -0.03 link
17.04.2024 18.04.2024 Goldsmith George Jay
10% Owner		 Salg 8.78 95 263 10850 0 -0.03 link
16.04.2024 18.04.2024 Malievskaia Ekaterina
10% Owner		 Salg 8.53 203 705 23881 0 -0.06 link
16.04.2024 18.04.2024 Malievskaia Ekaterina
10% Owner		 Salg 8.53 203 696 23880 0 -0.06 link
16.04.2024 18.04.2024 Goldsmith George Jay
10% Owner		 Salg 8.53 203 696 23880 0 -0.06 link
16.04.2024 18.04.2024 Goldsmith George Jay
10% Owner		 Salg 8.53 203 705 23881 0 -0.06 link
13.03.2024 14.03.2024 Malievskaia Ekaterina
Director		 Salg 10.8 185 792 17203 0 -0.04 link
13.03.2024 14.03.2024 Goldsmith George Jay
Director		 Salg 10.8 185 792 17203 0 -0.04 link
12.03.2024 14.03.2024 Malievskaia Ekaterina
Director		 Salg 10.58 166 529 15740 0 -0.04 link
12.03.2024 14.03.2024 Goldsmith George Jay
Director		 Salg 10.58 166 529 15740 0 -0.04 link
14.12.2023 15.12.2023 Goldsmith George Jay
Director		 Salg 7.81 10 754 1377 0 0 link
14.12.2023 15.12.2023 Malievskaia Ekaterina
Director		 Salg 7.81 10 754 1377 0 0 link
13.12.2023 15.12.2023 Goldsmith George Jay
Director		 Salg 7.82 22 326 2855 0 -0.01 link
13.12.2023 15.12.2023 Malievskaia Ekaterina
Director		 Salg 7.82 22 326 2855 0 -0.01 link

Institusjoner Volum Dele, %
Tcg Crossover Management, Llc 3858000 6.23
ARK Investment Management, LLC 2618871 4.23
Paradigm Biocapital Advisors LP 2265988 3.66
Vivo Capital, LLC 1608000 2.6
Citadel Advisors Llc 1565000 2.53
RA Capital Management, L.P. 1286000 2.08
Soleus Capital Management, L.P. 964550 1.56
Aisling Capital Management LP 964500 1.56
Rosalind Advisors, Inc. 798500 1.29
Affinity Asset Advisors, LLC 550000 0.89

ETF Dele, % Lønnsomhet for året, % Utbytte, %
AdvisorShares Psychedelics ETF 6.71965 845.99 0.20
PSYK ETF 5.26 0
ARK Genomic Revolution ETF 1.06932 -8.08 0.05494
Virtus LifeSci Biotech Clinical Trials ETF 0.82737 63.04 0.33
Putnam Sustainable Future ETF 0.29668 32.87 0.70689
SPDR S&P International Small Cap ETF 0.02797 8.94 3.10348



Veileder Stillingstittel Betaling Fødselsår
Mr. Stephen D. Schultz Senior Vice President of Investor Relations N/A
Dr. Greg Ryslik Ph.D. Chief Technology Officer N/A
Ms. Anne Benedict Chief People Officer N/A
Mr. Christopher Williams Chief Communications Officer N/A
Mr. Lars Christian Wilde Senior Advisor N/A 1986 (39 år)
Mr. Matthew Allen Owens General Counsel & Chief Legal Officer 659.53k 1977 (48 år)
Ms. Teri Loxam M.B.A. CFO, Principal Financial Officer & Principal Accounting Officer N/A 1973 (52 år)
Mr. Kabir Kumar Nath M.A., M.B.A. CEO & Director 1964 (61 år)
Dr. Guy Goodwin Chief Medical Officer 1948 (77 år)
Dr. Susan C. Stansfield Ph.D. Advisor

Adresse: United Kingdom, Altrincham WA DT, 1 Ashley Road - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.compasspathways.com